ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), a subgroup of breast cancer defined by the lack of expression of oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, accounts for 15 to 20% (2).